Zou et al., 2011 - Google Patents
p57Kip2 and p27Kip1 cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70Zou et al., 2011
View HTML- Document ID
- 6732116448389113230
- Author
- Zou P
- Yoshihara H
- Hosokawa K
- Tai I
- Shinmyozu K
- Tsukahara F
- Maru Y
- Nakayama K
- Nakayama K
- Suda T
- Publication year
- Publication venue
- Cell stem cell
External Links
Snippet
Cell cycle regulators play critical roles in the balance between hematopoietic stem cell (HSC) dormancy and proliferation. In this study, we report that cell cycle entry proceeded normally in HSCs null for cyclin-dependent kinase (CDK) inhibitor p57 due to compensatory …
- 101710006482 HSPA8 0 title abstract description 92
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Zou et al. | p57Kip2 and p27Kip1 cooperate to maintain hematopoietic stem cell quiescence through interactions with Hsc70 | |
de Almeida et al. | Dye-independent methods reveal elevated mitochondrial mass in hematopoietic stem cells | |
Volk et al. | A CHAF1B-dependent molecular switch in hematopoiesis and leukemia pathogenesis | |
Tomellini et al. | Integrin-α3 is a functional marker of ex vivo expanded human long-term hematopoietic stem cells | |
Hur et al. | CD82/KAI1 maintains the dormancy of long-term hematopoietic stem cells through interaction with DARC-expressing macrophages | |
Liu et al. | p53 regulates hematopoietic stem cell quiescence | |
Luo et al. | Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence | |
Lu et al. | Polycomb group protein YY1 is an essential regulator of hematopoietic stem cell quiescence | |
Takubo et al. | Regulation of the HIF-1α level is essential for hematopoietic stem cells | |
Matsumoto et al. | p57 is required for quiescence and maintenance of adult hematopoietic stem cells | |
Liang et al. | Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue | |
Luchsinger et al. | Mitofusin 2 maintains haematopoietic stem cells with extensive lymphoid potential | |
King et al. | The ubiquitin ligase Huwe1 regulates the maintenance and lymphoid commitment of hematopoietic stem cells | |
Moriggl et al. | Stat5 tetramer formation is associated with leukemogenesis | |
Rouault-Pierre et al. | HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress | |
Van Nguyen et al. | SUMO-specific protease 1 is critical for early lymphoid development through regulation of STAT5 activation | |
Galan-Caridad et al. | Zfx controls the self-renewal of embryonic and hematopoietic stem cells | |
Renström et al. | Secreted frizzled-related protein 1 extrinsically regulates cycling activity and maintenance of hematopoietic stem cells | |
Zhao et al. | Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo | |
Jude et al. | Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors | |
Jones et al. | Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells | |
Nakagawa et al. | Constitutive activation of the canonical NF-κB pathway leads to bone marrow failure and induction of erythroid signature in hematopoietic stem cells | |
Kim et al. | Identification of a stroma-mediated Wnt/β-catenin signal promoting self-renewal of hematopoietic stem cells in the stem cell niche | |
Sirin et al. | The orphan nuclear receptor Nurr1 restricts the proliferation of haematopoietic stem cells | |
Schreck et al. | Niche WNT5A regulates the actin cytoskeleton during regeneration of hematopoietic stem cells |